This content is machine translated Online training Swiss Oncology in Motion Chronic Lymphocytic Leukemia Module The Chronic Lymphocytic Leukemia module of Swiss Oncology in Motion includes articles by Prof. em. Richard Herrmann, MD, moderated presentations by PD Jeroen S. Goede, MD, Head of Hematology (Head…
View Post 1 min This content is machine translated Online training Swiss Oncology in Motion CME Module Chronic Lymphocytic Leukemia: Basics, Genetics and Guidelines Prof. em. Dr. Richard Herrmann in conversation with PD Dr. med. Jeroen S. Goede, Head of Hematology, Head of the Center for Lymphomas and Leukemias, Kantonsspital Winterthur Video Part 1/3:… CME-Test
View Post 1 min This content is machine translated Online training Swiss Oncology in Motion CME Module Chronic Lymphocytic Leukemia: Treatment Overview Prof. em. Dr. Richard Herrmann in conversation with Michael Gregor, M.D., Head of Hematology, Lucerne Cantonal Hospital Video Part 2/3: Treatment Overview CME-Test
View Post 1 min This content is machine translated Online training Swiss Oncology in Motion CME Module Chronic Lymphocytic Leukemia: Key Figures for Practice and Outlook for the Future Prof. em. Dr. Richard Herrmann in conversation with Prof. Dr. med. Thorsten Zenz, Senior Physician at the Center for Hematology and Oncology, University Hospital Zurich Video Part 3/3: Key figures… CME-Test
View Post 2 min This content is machine translated Colon Cancer Three cheers for the therapy The prognosis of patients with colon cancer harboring a mutation in the BRAF-V600 gene is markedly poor. If the therapy does not work, the probability of survival is only four…
View Post 1 min This content is machine translated Advanced bladder cancer Prolonged progression-free survival with combination therapy Preliminary study results suggest that the addition of immunotherapy to conventional chemotherapy may improve progression-free survival in patients with advanced bladder cancer. Is a paradigm shift on the horizon?
View Post 2 min This content is machine translated Excellent science Best Abstracts: the most important research results at a glance There is hardly any other discipline in which such great and rapid progress has been made as in oncology and hematology. As the studies honored as Best Abstracts demonstrate, immune…
View Post 3 min This content is machine translated Infantile hemangiomas The hematoma – sometimes more than just a cosmetic problem Infantile hemangiomas are the most common benign tumors in children. They are either congenital or develop within the first weeks of life. Therapy is indicated for complicated manifestations and impending…
View Post 2 min This content is machine translated Small cell lung carcinoma Combined therapy with checkpoint inhibitors is effective Advances in the treatment of small cell lung cancer have been scarce in recent years. Results of second studies now demonstrate a survival advantage for the combination of chemotherapy with…
View Post 2 min This content is machine translated Nasopharyngeal carcinoma Make the tumor shine?! Nasopharyngeal carcinoma is a rather rare tumor entity in Europe, which is often only detected at an advanced stage. With combined radiochemotherapy, the chances of cure are good in non-metastatic…
View Post 3 min This content is machine translated White skin cancer Well camouflaged – treated even better Light skin cancers are the result of long-term UV exposure, lack of sun protection and light skin. Basal cell and squamous cell carcinomas are among the most common skin tumors…
